By Neurolixis, Inc.
The US Food and Drug Administration (FDA) gave a positive response to Neurolixis' Investigational New Drug (IND) application for NLX-112.
Neurolixis launched a collaboration with the GALA® laboratory in Castres, France. GALA® is a platform of the Rapsodee/IMT Mines Albi research facility specialized in developing novel drug formulations.
By Fighting Parkinson's Drug Free
Howard Shifke knows a thing or two about Parkinson's disease. In his book "Fighting Parkinson's...and Winning: A memoir of my recovery from Parkinson's Disease," Shifke recounts the story of his developing Parkinson's, getting diagnosed, and his daily...
By Parkinson's Foundation
TheParkinson's Foundation is hosting its Annual Celebrate Spring New Yorkevent, whichwill take place on Wednesday, April 11, 2018 at Lavo located at 39 East 58th Street between Madison and Park Avenues.
By Peter Hunt Books
"The Lost Intruder, the Search for a Missing Navy Jet" (ISBN 1546334971) relates diver and former Navy pilot Peter M. Hunt's successful search of Puget Sound for an A-6 Intruder while battling Parkinson's disease.
By Mary Ann Liebert, Inc., publishers
Researchers have demonstrated the ability to generate dopaminergic neurons in the laboratory from induced pluripotent stem cells (iPSCs) derived from fibroblast cells of adult marmoset monkeys.
By Biodex Medical Systems, Inc.
Enhancing neuroplasticity with pattern sensory-enhanced movement
By Biotech Support Group
Biotech Support Group reports on a recent research article describing the simplicity and efficiency of their hemoglobin depletion technology for improving the signal from whole blood protein immunoblot analysis. The citation is: Lahut, Suna, et al.
By Neurodon LLC
Neurodon LLC has recently published a breakthrough study that paves the way for a new, effective way to treat Parkinson's disease. The novel strategy focuses on a process called endoplasmic reticulum stress, or ER stress.
By ARS Therapeutics
Parkinson's Disease (PD) affects one million people in the United States alone and seven million world-wide. Over 100,000 people died from PD in 2013 alone.